Race and Income Disparity in Ischemic Stroke Care: Nationwide Inpatient Sample Database, 2002 to 2008

被引:75
作者
Kimball, Matthew M. [1 ]
Neal, Dan [2 ]
Waters, Michael F. [3 ,4 ]
Hoh, Brian L. [1 ]
机构
[1] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Biostat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA
基金
美国国家卫生研究院;
关键词
Hospital charges; ischemic stroke; length of hospitalization; socioeconomic; thrombolytic; TISSUE-PLASMINOGEN ACTIVATOR; SOCIOECONOMIC-STATUS; UNITED-STATES; HOSPITAL VOLUME; THROMBOLYSIS; MORTALITY; ASSOCIATION; TIME; HEALTH; EPIDEMIOLOGY;
D O I
10.1016/j.jstrokecerebrovasdis.2012.06.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Health care disparities exist between demographic groups with stroke. We examined whether patients of particular ethnicity or income levels experienced reduced access to or delays in receiving stroke care. Methods: We studied all admissions for ischemic stroke in the Nationwide Inpatient Sample (NIS) database between 2002 and 2008. We used statistical models to determine whether median income or race were associated with intravenous (IV) thrombolysis treatment, in-hospital mortality, discharge disposition, hospital charges, and LOS in high- or low-volume hospitals. Results: There were a total of 477,474 patients with ischemic stroke: 10,781 (2.3%) received IV thrombolysis, and 380,400 (79.7%) were treated in high-volume hospitals. Race (P < .0001) and median income (P < .001) were significant predictors of receiving IV thrombolysis, and minorities and low-income patients were less likely to receive IV thrombolysis. Median income was a predictor of access to high-volume hospitals (P < .0001), with wealthier patients more likely to be treated in high-volume hospitals, which had lower mortality rates (P = .0002). Patients in high-volume hospitals were 1.84 times more likely to receive IV thrombolysis (P < .0001). Conclusions: African Americans, Hispanics, and low median income patients are less likely to receive IV thrombolysis for ischemic stroke. Low median income patients are less likely to be treated at high-volume hospitals. High-volume hospitals have lower mortality rates and a higher likelihood of treating patients with IV thrombolysis. There is evidence for an influence of socioeconomic status and racial disparity in the treatment of ischemic stroke.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 32 条
  • [1] Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients - An analysis of the nationwide inpatient sample 1999 to 2002
    Bateman, BT
    Schumacher, HC
    Boden-Albala, B
    Berman, MF
    Mohr, JP
    Sacco, RL
    Pile-Spellman, J
    [J]. STROKE, 2006, 37 (02) : 440 - 446
  • [2] Socioeconomic Differences in Stroke Incidence and Prognosis Under a Universal Healthcare System
    Cesaroni, Giulia
    Agabiti, Nera
    Forastiere, Francesco
    Perucci, Carlo Alberto
    [J]. STROKE, 2009, 40 (08) : 2812 - 2819
  • [3] Organization of a United States County System for Comprehensive Acute Stroke Care
    Cramer, Steven C.
    Stradling, Dana
    Brown, David M.
    Carrillo-Nunez, Ignacio M.
    Ciabarra, Anthony
    Cummings, Michael
    Dauben, Richard
    Lombardi, David L.
    Patel, Nirav
    Traynor, Elizabeth N.
    Waldman, Stephen
    Miller, Ken
    Stratton, Samuel J.
    [J]. STROKE, 2012, 43 (04) : 1089 - U299
  • [4] Racial-Ethnic Disparities in Stroke Care: The American Experience A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
    Cruz-Flores, Salvador
    Rabinstein, Alejandro
    Biller, Jose
    Elkind, Mitchell S. V.
    Griffith, Patrick
    Gorelick, Philip B.
    Howard, George
    Leira, Enrique C.
    Morgenstern, Lewis B.
    Ovbiagele, Bruce
    Peterson, Eric
    Rosamond, Wayne
    Trimble, Brian
    Valderrama, Amy L.
    [J]. STROKE, 2011, 42 (07) : 2091 - 2116
  • [5] Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association
    del Zoppo, Gregory J.
    Saver, Jeffrey L.
    Jauch, Edward C.
    Adams, Harold P., Jr.
    [J]. STROKE, 2009, 40 (08) : 2945 - 2948
  • [6] The importance of place of residence: Examining health in rural and nonrural areas
    Eberhardt, MS
    Pamuk, ER
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (10) : 1682 - 1686
  • [7] Comorbidity measures for use with administrative data
    Elixhauser, A
    Steiner, C
    Harris, DR
    Coffey, RN
    [J]. MEDICAL CARE, 1998, 36 (01) : 8 - 27
  • [8] Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475
  • [9] Regional Implementation of the Stroke Systems of Care Model Recommendations of the Northeast Cerebrovascular Consortium
    Gropen, Toby
    Magdon-Ismail, Zainab
    Day, David
    Melluzzo, Shannon
    Schwamm, Lee H.
    [J]. STROKE, 2009, 40 (05) : 1793 - 1802
  • [10] Race, socioeconomic status, and cause-specific mortality
    Howard, G
    Anderson, RT
    Russell, G
    Howard, VJ
    Burke, GL
    [J]. ANNALS OF EPIDEMIOLOGY, 2000, 10 (04) : 214 - 223